Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,439Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Breztri

02 4Cortiment

03 8Pulmicort

04 2Pulmicort

05 8Symbicort

06 5Symbicort

07 5Uceris

PharmaCompass

01

Brand Name : Pulmicort

Budesonide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pulmicort

arrow
2024 ACI Convention
Not Confirmed

Budesonide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 996

2019 Revenue in Millions : 1,466

Growth (%) : -32

blank

02

Brand Name : Uceris

Budesonide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Uceris

arrow
2024 ACI Convention
Not Confirmed

Budesonide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 6

2019 Revenue in Millions : 11

Growth (%) : -48

blank

03

Brand Name : Symbicort

Budesonide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Symbicort

arrow
2024 ACI Convention
Not Confirmed

Budesonide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 2,721

2019 Revenue in Millions : 2,495

Growth (%) : 9

blank

04

Brand Name : Symbicort

Budesonide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Symbicort

arrow
2024 ACI Convention
Not Confirmed

Budesonide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 0

2019 Revenue in Millions : 213

Growth (%) : -100

blank

05

arrow
2024 ACI Convention
Not Confirmed

06

Brand Name : Cortiment

Budesonide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Cortiment

arrow
2024 ACI Convention
Not Confirmed

Budesonide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 8

2019 Revenue in Millions : 5

Growth (%) : 70

blank

07

Brand Name : Pulmicort

Budesonide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pulmicort

arrow
2024 ACI Convention
Not Confirmed

Budesonide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 962

2020 Revenue in Millions : 996

Growth (%) : -3

blank

08

Brand Name : Breztri

Budesonide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Breztri

arrow
2024 ACI Convention
Not Confirmed

Budesonide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 203

2020 Revenue in Millions : 28

Growth (%) : 625

blank

09

Brand Name : Cortiment

Budesonide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Cortiment

arrow
2024 ACI Convention
Not Confirmed

Budesonide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 4

2020 Revenue in Millions : 7

Growth (%) : -42

blank

10

Brand Name : Uceris

Budesonide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Uceris

arrow
2024 ACI Convention
Not Confirmed

Budesonide

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 4

2020 Revenue in Millions : 5

Growth (%) : -31

blank